CHEMBRDG-BB 5877923
CAS4005-06-5
CHEMBRDG-BB 5877923 (CAS 4005-06-5, C16H12N2O3) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.
- CAS No.
- 4005-06-5
- Formula
- C16H12N2O3
- Mol. weight
- 280.28 g/mol
Chemical Specifications
Identifiers
| CAS number | 4005-06-5 |
|---|---|
| Product name | CHEMBRDG-BB 5877923 |
| Synonyms | CHEMBRDG-BB 5877923; 2-(2-METHYL-4-OXO-4 H-QUINAZOLIN-3-YL)-BENZOIC ACID; 2-(2-METHYL-4-OXOQUINAZOLIN-3(4H)-YL)BENZOIC ACID; 2-(2-methyl-4-oxoquinazolin-3(4H)-yl)benzoic acid(SALTDATA: FREE) |
| Molecular formula | C16H12N2O3 |
| Molecular weight | 280.28 g/mol |
Physical and chemical properties
| Boiling Point | 253.2 ( ℃ ) |
|---|
Packaging, Storage & Transport
| Available pack sizes | 5kg, 1kg, 500g, 100g, 50g, 10g |
|---|
Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.
Frequently Asked Questions
What is the CAS number of CHEMBRDG-BB 5877923?
The CAS Registry Number of CHEMBRDG-BB 5877923 is 4005-06-5. CHEMBRDG-BB 5877923 is also known as CHEMBRDG-BB 5877923; 2-(2-METHYL-4-OXO-4 H-QUINAZOLIN-3-YL)-BENZOIC ACID; 2-(2-METHYL-4-OXOQUINAZOLIN-3(4H)-YL)BENZOIC ACID.
What is the molecular formula and molecular weight of CHEMBRDG-BB 5877923?
The molecular formula of CHEMBRDG-BB 5877923 is C16H12N2O3, and its molecular weight is 280.28 g/mol.
How can I request a quotation for CHEMBRDG-BB 5877923?
Send an inquiry for CHEMBRDG-BB 5877923 (CAS 4005-06-5) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.
Request a Quote for CHEMBRDG-BB 5877923
Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.
Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.